Case Reports

One CHiP to rule them all? Mechanistic insight into carfilzomib-induced lung injury with neutrophil extracellular trap formation following cellular immunotherapy

Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Department of Pediatric Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Diagnostic and Interventional Radiology, Universitätsmedizin Mainz
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen
Medizinische Klinik und Poliklinik II, Uniklinikum Würzburg, Würzburg; Bayerisches Krebsforschungszentrum, partner site Würzburg
Medizinische Klinik und Poliklinik II, Uniklinikum Würzburg, Würzburg; Bayerisches Krebsforschungszentrum, partner site Würzburg
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Department of Pediatric Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF)
Haematologica Early view Feb 13, 2025 https://doi.org/10.3324/haematol.2024.286596